Entering text into the input field will update the search result below

Aeterna Zentaris (NASDAQ:AEZS) is up 8.5% premarket after announcing favorable results for a...

Aug. 30, 2011 9:19 AM ETAeterna Zentaris Inc. (AEZS) Stock, AEZS:CA StockAEZSBy: Eric Jhonsa, SA News Editor

Aeterna Zentaris (NASDAQ:AEZS) is up 8.5% premarket after announcing favorable results for a Phase 3 study related to its AEZS-130 drug for treating adult growth hormone deficiency. The company now plans to consult with the FDA regarding the submission of a new drug application (NDA).

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AEZS
--
AEZS:CA
--